Explore the latest on Entero Healthcare Solutions IPO, from GMP to subscription status and key details. Decide whether to apply or not. Your comprehensive guide to this groundbreaking healthcare IPO.
The financial landscape is abuzz with the opening of Entero Healthcare Solutions IPO today. In this article, we delve into the intricacies of this IPO, covering crucial aspects such as GMP, subscription status, review, and other essential details. Join us on this journey as we navigate through the offerings of Entero Healthcare Solutions Limited and help you make an informed decision on whether to participate in this IPO.
Market watchers report that Entero Healthcare Solutions’ IPO GMP is now ₹126
The Grey Market Premium (GMP) for Entero Healthcare Solutions IPO stands at an impressive ₹126, as reported by market observers. This early indication of premium pricing in the grey market suggests a high level of investor interest in the offering. The GMP serves as an initial gauge for potential investors, hinting at the IPO’s perceived value in the market.
Investors keen on understanding market sentiments often turn to GMP as a valuable metric. The current GMP of ₹126 reflects a positive outlook, showcasing confidence in Entero Healthcare Solutions IPO. As the day progresses, it will be intriguing to observe any fluctuations and gauge the dynamic nature of market sentiments.
Entero Healthcare Solutions price band and details
The IPO price band for Entero Healthcare Solutions is set between ₹1,195 and ₹1,258 per equity share, with a face value of ₹10. This range provides investors with options, and the book build issue aims to raise a substantial ₹1600 crore, with ₹1000 crore directed towards fresh share issuance.
Understanding the price band is crucial for investors to assess their investment potential. The range of ₹1,195 to ₹1,258 per share offers flexibility, catering to a diverse investor base. This aligns with Entero Healthcare Solutions’ goal of raising funds for expansion and innovation in the healthcare sector.
Entero Healthcare Solutions subscription status
By 11:33 AM on the first day of bidding, the book build issue has been subscribed 0.03 times, with the retail portion booked 0.17 times. The employees’ portion has seen a subscription of 0.14 times, indicating varying levels of interest among different investor categories.
Early subscription figures provide insights into investor appetite. The 0.03 times subscription by mid-morning suggests a measured interest, and the retail portion’s 0.17 times booking indicates retail investors’ enthusiasm. Monitoring subscription status can offer valuable cues for potential investors looking to gauge overall market interest.
Important Entero Healthcare Solutions details
Let’s break down the crucial details that investors need to know about Entero Healthcare Solutions IPO:
Entero Healthcare Solutions IPO GMP:
Shares of the company are trading at a premium of ₹126 in the grey market today, affirming positive market sentiment.
Entero Healthcare Solutions IPO date:
The public issue has commenced today and will remain open for bidding until 13th February 2024.
Entero Healthcare Solutions price:
The price band for the public issue is set at ₹1195 to ₹1258 per equity share, providing investors with a clear range for participation.
Entero Healthcare Solutions IPO size:
The company aims to raise ₹1600 crore, with ₹1000 crore directed towards the issuance of fresh shares.
Entero Healthcare Solutions IPO lot size:
Investors can apply in lots, with one lot comprising 11 company shares, allowing for varied investment sizes.
Entero Healthcare Solutions IPO allotment date:
Finalization of share allocation is expected on 14th February 2024.
Entero Healthcare Solutions registrar:
Link Intime India Private Limited has been appointed as the official registrar for the book build issue.
Entero Healthcare Solutions listing:
It is suggested that the public issue be listed on the BSE and NSE.
Entero Healthcare Solutions IPO listing date:
Following the T+3 listing rule, the IPO is likely to be listed on 16th February 2024, offering investors a swift listing process.
These details provide a comprehensive overview of Entero Healthcare Solutions IPO, aiding investors in making informed decisions. From the lot size to the listing date, each aspect is crucial for investors looking to participate in this healthcare venture.
Entero Healthcare Solutions IPO: A Contemplation Worthy of Your Consideration?
In scrutinizing the Entero Healthcare Solutions IPO, Ventura Securities, in a resounding endorsement marked “subscribe” for the book build issue, asserts that Entero Healthcare Solutions has risen as a pivotal entity in the healthcare distribution panorama of India. The company has witnessed phenomenal expansion, weaving an intricate web and establishing a resilient network. Covering an extensive terrain, their services span across 81,400 pharmacies and 3,400 hospitals, effectively meeting the demands of both individual consumers and institutional entities. The brokerage further articulates that Entero Healthcare Solutions achieved the most accelerated augmentation in operational magnitude among healthcare product distributors in India during the fiscal years spanning from FY19 to FY22.
BP Equities, in a parallel accord, affixes a subscribe label to the public issue, contending that the valuation stands at a P/E ratio of 111.2x on the upper echelon of the price band, grounded on FY24E earnings. This, according to them, reflects a fair assessment relative to its peers. Hence, they advocate for a resounding SUBSCRIBE recommendation for the issue.
FAQs (Frequently Asked Questions):
Q: Is the current GMP favorable for investing in Entero Healthcare Solutions IPO?
A: Yes, the GMP of ₹126 indicates positive market sentiment, making it an attractive option for potential investors.
Q: What is the closing date for Entero Healthcare Solutions IPO?
A: The IPO will remain open for bidding until 13th February 2024.
Q: Can I apply for a partial lot in Entero Healthcare Solutions IPO?
A: No, investors can only apply in lots, with one lot comprising 11 company shares.
Q: When will the share allocation be finalized?
A: The finalization of share allocation is anticipated on 14th February 2024.
Q: Who is the official registrar for Entero Healthcare Solutions IPO?
A: Link Intime India Private Limited has been appointed as the official registrar for the book build issue.
Q: On which stock exchanges is Entero Healthcare Solutions IPO proposed for listing?
A: The public issue is proposed for listing on both BSE and NSE.
As Entero Healthcare Solutions IPO opens its doors to investors, the combination of a promising GMP, reasonable price band, and early subscription interest sets an optimistic tone. This comprehensive guide equips potential investors with the necessary information to navigate this healthcare venture successfully.
Remember, investing involves risks, and it’s advisable to conduct thorough research and, if needed, consult financial experts before making investment decisions.
Open Your Demat Account with Discount Brokers:
ZERODHA 1) : https://zerodha.com/open-account?c=EJ4366
Angelone 2) : https://tinyurl.com/2gloc3g6 or